Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-13911
Kolev, V; Mandinova, A; Guinea-Viniegra, J; Hu, B; Lefort, K; Lambertini, C; Neel, V; Dummer, R; Wagner, E F; Dotto, G P (2008). EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nature Cell Biology, 10(8):902-911.
- Registered users only
The Notch1 gene has an important role in mammalian cell-fate decision and tumorigenesis. Upstream control mechanisms for transcription of this gene are still poorly understood. In a chemical genetics screen for small molecule activators of Notch signalling, we identified epidermal growth factor receptor (EGFR) as a key negative regulator of Notch1 gene expression in primary human keratinocytes, intact epidermis and skin squamous cell carcinomas (SCCs). The underlying mechanism for negative control of the Notch1 gene in human cells, as well as in a mouse model of EGFR-dependent skin carcinogenesis, involves transcriptional suppression of p53 by the EGFR effector c-Jun. Suppression of Notch signalling in cancer cells counteracts the differentiation-inducing effects of EGFR inhibitors while, at the same time, synergizing with these compounds in induction of apoptosis. Thus, our data reveal a key role of EGFR signalling in the negative regulation of Notch1 gene transcription, of potential relevance for combinatory approaches for cancer therapy.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic|
|DDC:||610 Medicine & health|
|Deposited On:||19 Feb 2009 12:45|
|Last Modified:||17 Jul 2014 06:09|
|Publisher:||Nature Publishing Group|
|Citations:||Web of Science®|
Scopus®. Citation Count: 80
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page